Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia

Clinical trial NCT00776503 · COMPLETED

Trial details

NCT number: NCT00776503
Sponsor: Groupe Francophone des Myelodysplasies
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2008-05-01
Primary completion: 2011-11-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.